Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

2002 • 6,780 citations

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

2000 • 5,760 citations

Applied Linear Regression Models

1997 • 4,817 citations

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes

2004 • 4,752 citations

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

2003 • 3,816 citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

2002 • 3,483 citations

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>

2001 • 2,473 citations

Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

2003 • 2,434 citations

Graphical Methods for Data Analysis.

1984 • 2,350 citations

Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis

2004 • 2,346 citations

C-Reactive Protein Levels and Outcomes after Statin Therapy

2005 • 2,249 citations

American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus)31When citing this document, the American College of Cardiology would appreciate the following citation format: Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. ACC Clinical Expert Consensus Document on Standards for the acquisition, measurement and reporting …

2001 • 2,120 citations

Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

2003 • 1,693 citations

Effect of Statin Therapy on C-Reactive Protein Levels

2001 • 1,627 citations

Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients

2003 • 1,177 citations

A Self-Fulfilling Prophecy

2002 • 1,039 citations

Intravascular Ultrasound

2001 • 828 citations

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

1993 • 809 citations

C-Reactive Protein in the Arterial Intima

2000 • 590 citations

Isoprenoids as mediators of the biological effects of statins

2002 • 433 citations

Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

2003 • 427 citations

Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events

2003 • 418 citations

Simvastatin Lowers C-Reactive Protein Within 14 Days

2002 • 351 citations

Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children

2002 • 322 citations

Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.

1997 • 160 citations

Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration

2003 • 56 citations

Usefulness of lowering low-density lipoprotein cholesterol to <70 mg/dl and usefulness of C-reactive protein in patient selection

2003 • 17 citations